PHC Holdings (PHCC.F) Stock Overview
Provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 2/6 |
| Dividends | 2/6 |
PHCC.F Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
PHC Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥7.09 |
| 52 Week High | JP¥7.09 |
| 52 Week Low | JP¥5.98 |
| Beta | 0.80 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -32.48% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHCC.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.9% |
| 1Y | n/a | -3.7% | 12.5% |
Return vs Industry: Insufficient data to determine how PHCC.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how PHCC.F performed against the US Market.
Price Volatility
| PHCC.F volatility | |
|---|---|
| PHCC.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 9.3% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PHCC.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine PHCC.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1948 | 9,041 | Kay Deguchi | phchd.com |
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables; cell growth and preservation, such as CFC-free ultra-low temperature freezers, CO2 incubators, and live cell metabolic analyzer and cell expansion bioreactor system; and diagnostic testing comprising clinical testing, diagnostic reagents, and digital diabetes management solutions.
PHC Holdings Corporation Fundamentals Summary
| PHCC.F fundamental statistics | |
|---|---|
| Market cap | US$914.07m |
| Earnings (TTM) | US$36.89m |
| Revenue (TTM) | US$2.29b |
Is PHCC.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHCC.F income statement (TTM) | |
|---|---|
| Revenue | JP¥361.11b |
| Cost of Revenue | JP¥196.52b |
| Gross Profit | JP¥164.59b |
| Other Expenses | JP¥158.76b |
| Earnings | JP¥5.83b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Feb 12, 2026
| Earnings per share (EPS) | 46.05 |
| Gross Margin | 45.58% |
| Net Profit Margin | 1.61% |
| Debt/Equity Ratio | 170.0% |
How did PHCC.F perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/21 00:41 |
| End of Day Share Price | 2025/11/06 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PHC Holdings Corporation is covered by 9 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ritsuo Watanabe | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |
| Akinori Ueda | Goldman Sachs |